VERISIM LIFE
VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. VeriSIM offers a range of translational-based solutions, customized for the pre-clinical and clinical programs. These offerings are all centered around their proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses.
VERISIM LIFE
Industry:
Biotechnology Health Care
Founded:
2017-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.verisimlife.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
21.66 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt Amazon
Similar Organizations
1200 Pharma
1200 Pharma is a medicinal chemistry technology company that accelerates pre-clinical drug discovery and clinical approval timelines.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-11 | Molomics Biotech SL | Molomics Biotech SL acquired by VeriSIM Life | N/A |
Investors List
Debiopharm Innovation Fund
Debiopharm Innovation Fund investment in Series A - VeriSIM Life
Serra Ventures
Serra Ventures investment in Series A - VeriSIM Life
Intel Capital
Intel Capital investment in Series A - VeriSIM Life
Morpheus Ventures
Morpheus Ventures investment in Series A - VeriSIM Life
OCA Ventures
OCA Ventures investment in Series A - VeriSIM Life
Susa Ventures
Susa Ventures investment in Series A - VeriSIM Life
National Science Foundation
National Science Foundation investment in Grant - VeriSIM Life
Stage Venture Partners
Stage Venture Partners investment in Seed Round - VeriSIM Life
Intel Capital
Intel Capital investment in Seed Round - VeriSIM Life
Susa Ventures
Susa Ventures investment in Seed Round - VeriSIM Life
Official Site Inspections
http://www.verisimlife.com Semrush global rank: 5.05 M Semrush visits lastest month: 1.61 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "VeriSIM Life"
VeriSIM Life | AI Drug Discovery & Development
Our AI-driven drug development services deliver insights for pharmaceutical companies, biotechs, and academic & research institutions. We also partner in risk-sharing collaborations to develop …See details»
Welcome to BIOiSIMTM │ Drug Discovery
VeriSIM Life’s first-in-class, drug decision engine, BIOiSIM, offers actionable insights of unprecedented value to the drug development industry. Avoid the design and pursuit of dead end candidates.See details»
About us | Diversity, Inclusion, and Belonging | VeriSIM …
We are a dedicated team of scientists, modelers, chemists and software engineers that are passionate about addressing the need for better prediction in healthcare. VeriSIM was founded in 2017 by Dr. Jo Varshney, a multi …See details»
VeriSIM Life - Crunchbase Company Profile & Funding
Contact Email [email protected] VeriSIM Life is a computational bioplatform that predicts the clinical outcomes of new drugs before clinical trials. VeriSIM offers a range of translational …See details»
VeriSIM Life - LinkedIn
VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow,...See details»
VeriSIM Life - VentureRadar
Website: http://verisimlife.com Develops a drug decision engine using AI and ML techniques, reducing time, cost, and animal testing in pharmaceutical development while optimizing …See details»
VeriSIM Life Awarded Federal Grant from National Institutes of …
Apr 19, 2022 · VeriSIM Life has developed a sophisticated computational platform that leverages advanced AI and ML techniques to improve drug discovery and development by greatly …See details»
Debiopharm's portfolio company VeriSIM Life - Debiopharm
VeriSIM Life addresses the translational gap in drug development, de-risking R&D decisions through their computational BIOiSIMTM platform. Using AI and ML, BIOiSIMTM models the …See details»
Our Pipeline - verisimlife.com
By expanding our pipeline with precision-driven assets across diverse diseases, VeriSIM Life is advancing a powerful, scalable approach to drug development that addresses urgent patient …See details»
VeriSIM Life Secures a Federal Grant to Create a Drug …
Mar 2, 2021 · VeriSIM Life has developed a whole-body biosimulation platform driven by AI and machine learning (ML), that accurately predicts the clinical efficacy of new drugs before human …See details»
VeriSIM Life Secures $15 Million Series A Funding
Jan 6, 2022 · VeriSIM Life has developed a sophisticated computational platform that leverages advanced AI and ML techniques to significantly improve drug discovery and development by greatly reducing the...See details»
VeriSIM Life Company Profile 2024: Valuation, Funding ... - PitchBook
VeriSIM Life was founded in 2017. Where is VeriSIM Life headquartered? VeriSIM Life is headquartered in San Francisco, CA. What is the size of VeriSIM Life? VeriSIM Life has 26 …See details»
VeriSIM Careers │ Drug Discovery & Development Technology
We offer Medical, Dental, Vision, and Commuter Benefits in addition to unlimited vacation and catered lunches at least once per week. Many roles provide equity as part of compensation. …See details»
VeriSIM Life and Total Brain Announce Strategic ... - Business Wire
May 26, 2022 · The partnership will pioneer the integration of Total Brain’s proprietary mental health and brain performance database with VeriSIM Life’s BIOiSIMâ„¢ AI-enabled drug …See details»
VeriSIM Life: Using AI to build translational indices to push better ...
Apr 4, 2023 · Jo Varshney, Ph.D., is the founder and CEO of VeriSIM Life, a startup developing disease-specific simulation software designed to replace animal drug testing by using artificial …See details»
BIOiSIM offers predictive AI capabilties for drug candidates
Feb 8, 2024 · VeriSIM Life, a San Francisco-based startup, has created BIOiSIM, an AI-powered platform that simulates drug compound behavior in the human body by acting like a virtual …See details»
Sign up or Login | VeriSIM Life
[email protected] 415.991.3783. Our Platform. BIOiSIM AtlasGEN Testimonials. Platform Ecosystem. Drug Repurposing. Formulation. Drug-drug interactions. Safety-toxicity profiles. …See details»
VeriSIM Life Announces Acquisition of Molomics Biotech
May 11, 2022 · Founded in 2015 in Barcelona, Catalonia, Spain, Molomics integrates AI with Human Collective Intelligence (HCI) to determine novel chemical structures with high …See details»
VeriSIM Life - Craft
VeriSIM Life is a company that provides drug discovery and development technology solutions. It develops BIOiSIM, a platform used before preclinical animal trials start. The company offers …See details»
VeriSIM Life Secures $15 Million Series A Funding
VeriSIM’s BIOiSIM platform, driven by artificial intelligence (AI) and machine learning (ML), de-risks R&D decisions by providing meaningful insights much earlier in the drug development …See details»